Lista de

Amphetamine
11
"Pedunculopontine arousal system(Ft physiology—effects of psychostimulant abuse" (2015) Urbano, F.J.;Bisagno, V.;González, B. (...)Garcia-Rill, E. Sleep Science. 8(3):162-168
"Drug Abuse and the RAS" (2015) Urbano, F.J.; Bisagno, V.; Garcia-Rill, E. Waking and the Reticular Activating System in Health and Disease:277-289
"Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine" (2004) Avale, M.E.; Nemirovsky, S.I.; Raisman-Vozari, R.; Rubinstein, M. Journal of Neuroscience Research. 78(2):289-296
"Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine" (2004) Avale, M.E.; Nemirovsky, S.I.; Raisman-Vozari, R.; Rubinstein, M. Journal of Neuroscience Research. 78(2):289-296
"The dopamine D 2 , but not D 3 or D 4 , receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice" (1999) Ralph, R.J.;Varty, G.B.;Kelly, M.A. (...)Geyer, M.A. Journal of Neuroscience. 19(11):4627-4633
"The dopamine D 2 , but not D 3 or D 4 , receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice" (1999) Ralph, R.J.;Varty, G.B.;Kelly, M.A. (...)Geyer, M.A. Journal of Neuroscience. 19(11):4627-4633
"The dopamine D 2 , but not D 3 or D 4 , receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice" (1999) Ralph, R.J.;Varty, G.B.;Kelly, M.A. (...)Geyer, M.A. Journal of Neuroscience. 19(11):4627-4633
"Detection of drug effects on neurons: Protein synthesis inhibition by low doses of amphetamine" (1989) Berninsone, P.M.; Bruses, J.L.; Azcurra, J.M. Methods and Findings in Experimental and Clinical Pharmacology. 11(4):249-253
"Detection of drug effects on neurons: Protein synthesis inhibition by low doses of amphetamine" (1989) Berninsone, P.M.; Bruses, J.L.; Azcurra, J.M. Methods and Findings in Experimental and Clinical Pharmacology. 11(4):249-253